- Home
- » Tags
- » Opioid antagonist
Top View
- Coadministration of an Opioid Agonist and Antagonist for Pain Control
- Truncated Mu Opioid Receptor Splice Variants As Targets for Powerful Pain Relief with Reduced Side Effects
- Asymptomatic Celiac Disease Leo Pruimboom1,2* and Karin De Punder1,3
- Antagonists in the Medical Management of Opioid Use Disorders: Historical and Existing Treatment Strategies
- United States Patent (10) Patent No.: US 9,650,338 B1 Martirosyan (45) Date of Patent: May 16, 2017
- 2019 -- S 0409 Substitute a State of Rhode Island
- Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism Which Do Not Recruit
- Antinociceptive Action of Isolated Mitragynine from Mitragyna Speciosa Through Activation of Opioid Receptor System
- Delta-Opioid Receptor
- Guidelines for the Psychosocially Assisted Pharmacological Treatment
- BUPRENORPHINE for Opioid Use Disorder
- Embossable and Writable Multilaminate Backing
- Preventing Opioid Overdose Deaths with Take-Home Naloxone
- United States Patent (19) 11 Patent Number: 5,866,164 Kuczynski Et Al
- National Practice Guideline
- 2018 Evidence-Based Strategies for Preventing Opioid Overdose
- House of Representatives Staff Analysis Bill #: Cs/Hb
- Undesignated Opioid Antagonist Report, School Year 2019-20
- Transdemal Delivery of Opioid Antagonist Prodrugs Audra L
- Kratom Baitem
- (12) United States Patent (10) Patent No.: US 8,791,093 B2 G00 Berman (45) Date of Patent: Jul
- Naloxone: the Opioid Reversal Drug That Saves Lives How Healthcare Providers and Patients Can Better Utilize This Life-Saving Drug
- Naloxone As a Mu-Receptor Antagonist
- Briefing Document
- Standing Order for Registered Pharmacist Naloxone
- Positive Results from Human PK Study Assessing Orexo's Intranasal
- Biol. Pharm. Bull. 40(3): 278-283 (2017)
- Opioid A4: Antidotes in Depth
- Neurobiology of Kratom and Its Main Alkaloid Mitragynine
- Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose
- New University Laboratory Bridges Development Path for Promising
- Naloxone for Opioid Overdose
- Faqs - Naloxone